Nanocage-Therapeutics Prevailing Phagocytosis and Immunogenic Cell Death Awakens Immunity against Cancer
- Authors
- Lee, Eun Jung; Nam, Gi-Hoon; Lee, Na Kyeong; Kih, Minwoo; Koh, Eunee; Kim, Yoon Kyoung; Hong, Yeonsun; Kim, Soyoun; Park, Seung-Yoon; Jeong, Cherlhyun; Yang, Yoosoo; Kim, In-San
- Issue Date
- 2018-03-08
- Publisher
- WILEY-V C H VERLAG GMBH
- Citation
- ADVANCED MATERIALS, v.30, no.10
- Abstract
- A growing appreciation of the relationship between the immune system and the tumorigenesis has led to the development of strategies aimed at "re-editing" the immune system to kill tumors. Here, a novel tactic is reported for overcoming the activation-energy threshold of the immunosuppressive tumor microenvironment and mediating the delivery and presentation of tumor neoantigens to the host's immune system. This nature-derived nanocage not only efficiently presents ligands that enhance cancer cell phagocytosis, but also delivers drugs that induce immunogenic cancer cell death. The designed nanocage-therapeutics induce the release of neoantigens and danger signals in dying tumor cells, and leads to enhancement of tumor cell phagocytosis and cross-priming of tumor specific T cells by neoantigen peptide-loaded antigen-presenting cells. Potent inhibition of tumor growth and complete eradication of tumors is observed through systemic tumor-specific T cell responses in tumor draining lymph nodes and the spleen and further, infiltration of CD8+ T cells into the tumor site. Remarkably, after removal of the primary tumor, all mice treated with this nanocage-therapeutics are protected against subsequent challenge with the same tumor cells, suggesting development of lasting, tumor-specific responses. This designed nanocage-therapeutics "awakens" the host's immune system and provokes a durable systemic immune response against cancer.
- Keywords
- SIRP-ALPHA; COMBINATION IMMUNOTHERAPY; HUMAN FERRITIN; DRUG-DELIVERY; TUMORS; NANOPARTICLE; THERAPY; CD47; NEOANTIGENS; MUTATIONS; SIRP-ALPHA; COMBINATION IMMUNOTHERAPY; HUMAN FERRITIN; DRUG-DELIVERY; TUMORS; NANOPARTICLE; THERAPY; CD47; NEOANTIGENS; MUTATIONS; CD47 blockade; immunogenic cell death; intrinsic anticancer vaccination; nanocages; therapeutics
- ISSN
- 0935-9648
- URI
- https://pubs.kist.re.kr/handle/201004/121609
- DOI
- 10.1002/adma.201705581
- Appears in Collections:
- KIST Article > 2018
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.